December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about fda

Recent news which mentions fda

< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
32 33 Next >
Psychedelics And Mental Health: FDA Stalls, But States Forge Ahead
Tickers MDMA NEWS
Tags Psychedelics Market News MDMA
From Benzinga
FDA Allows Resumption Of BioNTech/MediLink Therapeutics Partnered Phase 1 Study For Cancer Drug With Lower Dose
Tickers BNTX NEWS
Tags BNTX Top Stories News
From Benzinga
Incyte Seeks Expanded FDA Approval For Lymphoma Drug After Releasing Promising Topline Data From Late-Stage Study
Tickers INCY NEWS
Tags Biotech Benzinga Movers
From Benzinga
FDA Approves AstraZeneca's Blockbuster Cancer Drug, Imfinzi, In Combination With Chemo For Non-Small Cell Lung Cancer
Tickers AZN NEWS
Tags Biotech AZN Benzinga
From Benzinga
Why Is Small-Cap Tempest Therapeutics Stock Trading Higher On Thursday?
Tickers NEWS RHHBY TPST
Tags Small Cap TPST Briefs
From Benzinga
FDA Approves Incyte/Syndax Partnered Drug For Chronic Graft-Versus-Host Disease, A Post-Transplant Complication
Tickers INCY NEWS SNDX
Tags Benzinga Biotech General
From Benzinga
FDA Approves Gilead's Seladelpar For Inflammatory Liver Disease, Acquired Via $4B CymaBay Deal
Tickers GILD NEWS
Tags Large Cap GILD FDA
From Benzinga
Kaya Holdings Advocates For Psilocybin As FDA Rejects MDMA For PTSD Treatment
Tickers KAYS NEWS
Tags psilocybin therapy KAYS Government
From Benzinga
EXCLUSIVE: Avalon's Lab Services MSO Poised To Commercialize FDA-Registered External Male Catheter Device
Tickers ALBT NEWS
Tags Benzinga FDA Briefs
From Benzinga
MDMA Therapy Papers Retracted Amid Ethical Concerns At Lykos Study Site
Tags Cannabis Multidisciplinary Association for Psychedelic Studies (MAPS) Psychedelic Research
From Benzinga
FDA Backs Off Joint Study On Kratom And Psychedelics Amidst Public Criticism
Tickers NEWS
Tags Regulations Psychedelics Government
From Benzinga
Ascendis' Hypoparathyroidism Drug Scores FDA Approval As First and Only Treatment, Replacing Takeda's Drug Discontinued Due To Supply Issues
Tickers ASND NEWS TAK
Tags Equities Large Cap Briefs
From Benzinga
Delay Hits Humacyte's Bioengineered Human Tissue Implant For Vascular Trauma Injuries, FDA Extends Time To Review
Tickers HUMA NEWS
Tags why it's moving Briefs FDA
From Benzinga
Heart Failure-Focused scPharmaceuticals Secures FDA Approval For Expanded Use Of Furoscix, Receives Funding To Expand Commercialization
Tickers NEWS SCPH
Tags General Trading Ideas Health Care
From Benzinga
< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.